The effect of typical and atypical neuroleptics on the expression of cytochrome P450 isoenzymes 1A2 (CYP1A2) and 3A4 (CYP3A4) in human hepatocytes.

2014/15/N/NZ7/02955

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Farmakologii PAN

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Agnieszka Basińska-Ziobroń

Number of co-investigators in the project: 2

Call

PRELUDIUM 8 – announced on 2014-09-15

Amount awarded
99 960 PLN
Project start date
2015-09-02
Project end date
2018-07-01
Project duration
34 months (the same as in the proposal)
Project status
Project settled

Information in the final report

Publication in academic press/journals (1)

  1. Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4

    Authors:
    Danek P.J., Basińska-Ziobroń A., Wójcikowski J., Daniel W.A.
    Academic press:
    Pharmacological Reports (year: 2020, volume: -, pages: -), Publisher: Springer Nature
    Status:
    Published
    DOI:
    10.1007/s43440-020-00157-4 – link to the publication

Articles in post-conference publications (1)

  1. Clozapine and levomepromazine induce the cytochrome P450 isoenzyme CYP3A4, but not CYP1A1/2, in human hepatocytes

    Authors:
    Danek P., Basińska-Ziobroń A., Daniel W.A., Wójcikowski J.
    Conference:
    30th ECNP Congress, Paris, France (year: 2017, pages: S927), Publisher: Elsevier
    Date:
    conference 2-5 wrzesień
    Status:
    Published
    DOI:
    link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski